For the Culture By The Culture. ISSN: 3064-9331.
Saint Lucia has selected GrowerIQ as its national seed-to-sale traceability backbone, effectively finalizing a digital surveillance grid for its cannabis industry. By mandating enterprise software before establishing licensing frameworks, the government risks automating the exclusion of legacy farmers. This move trades cultural sovereignty for state-managed control, turning the cannabis industry into an extension of the database.
Virginia legalized possession, but Governor Abigail Spanberger sabotaged the retail market. By delaying sales until 2027 and gutting equity provisions, the Commonwealth institutionalized a half-legal trap. Consumers now navigate a system that treats possession as a right but supply as a crime, fueling an unchecked illicit market while abandoning promised reform. Spanberger’s public safety rhetoric is clearly a mask for obstruction.
4/20 has been hollowed out by branding, corporate silence, and a culture that forgot its own history. While the industry sells holiday merch, Singapore executed a man for cannabis. The movement that once fought for autonomy now treats the plant like a commodity. This piece examines the cost of that betrayal and the culture left behind.
Ed Rosenthal recounts how the magazine was born not from psychedelic myth but from hard numbers. Rolling paper import data, underground press experience, and market logic revealed a massive hidden cannabis audience. His account challenges the romantic origin story and offers a rare firsthand look at the early mechanics behind one of cannabis culture’s most influential publications.
Cannabis is often labeled addictive, but the science tells a more precise story. This piece breaks down cannabis use disorder, how it is defined, and why mild, moderate, and severe cases get flattened into one fear-driven narrative. The result is a distorted public understanding of risk that fuels policy, perception, and misinformation.
Australia’s medical cannabis system expanded rapidly through telehealth and high-volume prescribing. Now regulators are tightening oversight. The TGA and AHPRA are increasing scrutiny on prescribing practices, signaling a shift from rapid patient access toward stricter clinical control that could reshape how doctors prescribe and how patients obtain treatment.
